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We thank Rinkoo Dalan for the comments on our paper 
(1, 2). We agree that although the reduction in diabetes risk 
with vitamin D supplementation among people at high risk 
for diabetes appears to be moderate (~ 12% relative risk re-
duction compared to placebo) (3), certain individuals may de-
rive a higher (or lower) benefit based on certain characteristics. 
For example, in the simplest demonstration of such heterogen-
eity, vitamin D supplementation reduced diabetes risk by 62% 
among participants in the Vitamin D and Type 2 Diabetes 
(D2d) study who had a baseline serum 25-hydroxyvitamin D 
(25[OH]D) level of less than 12 ng/mL (30 mmol/L) (2).
Consistent with the focus of the scientific community on 
precision nutrition, we agree that we need to better under-
stand responsiveness to vitamin D supplementation for spe-
cific outcomes of interest. The vitamin D response index is an 
interesting concept that reflects activation of the vitamin D re-
ceptor, and it is determined on the basis of measuring vitamin 
D–triggered changes in the expression of 24 target genes in 
peripheral blood mononuclear cells and 12 clinical and bio-
chemical parameters (4). There are at least 2 limitations: 
1) Although such an index may reflect vitamin D–induced 
changes in specific response parameters, these changes may 
not necessarily translate to clinically meaningful outcomes, 
such as lowering diabetes risk. 2)  Low-, mid-, and high-
responders are determined with statistical means within a 
specific cohort but that can be calculated only retrospectively; 
specific cutoffs to define degree of response need to be estab-
lished for use in real time in research or in the clinical setting.
The author also suggests that daily, steady exposure to 
vitamin D is preferred over intermittent exposure for op-
timal benefit, and we agree. In a secondary analysis from 
the D2d study, we reported that participants who received 
the active intervention (100 mcg [4000 units] of vitamin 
D
3 daily) and maintained high 25(OH)D levels that were 
stable throughout the trial period had the lowest risk of 
diabetes, whereas participants in the placebo group who 
maintained similar overall 25(OH)D levels that fluctuated 
during follow-up did not derive significant benefit (5).
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